Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Drinks Industry News How Kirin’s pivot to healthcare could reshape the future of Four Roses bourbon Kirin Holdings is reportedly considering selling the Four Roses bourbon brand for around US$1 billion. Find out the strategic reasons behind the move. byPallavi MadhirajuOctober 26, 2025